Post-COVID-19 condition in the German working population: A cross-sectional study of 200,000 registered stem cell donors

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • Stefanie N Bernas - , Center for Regenerative Therapies Dresden, DKMS Clinical Trials Unit, Stem Cell Donor Registry, University Hospital Tübingen (Author)
  • Henning Baldauf - , DKMS Clinical Trials Unit (Author)
  • Ruben Real - , DKMS Clinical Trials Unit (Author)
  • Jürgen Sauter - , DKMS Clinical Trials Unit (Author)
  • Jan Markert - , DKMS Clinical Trials Unit (Author)
  • Sarah Trost - , DKMS Clinical Trials Unit (Author)
  • Kristin Tausche - , Department of internal Medicine I, Division of Pulmonology (Author)
  • Uta Behrends - , Klinikum Rechts der Isar (MRI TUM) (Author)
  • Alexander H Schmidt - , DKMS Clinical Trials Unit (Author)
  • Johannes Schetelig - , Department of internal Medicine I, DKMS Clinical Trials Unit (Author)

Abstract

BACKGROUND: The SARS-CoV-2 pandemic has strained health systems worldwide, and infection numbers continue to rise. While previous data have already shown that many patients suffer from symptoms for months after an acute infection, data on risk factors and long-term outcomes are incomplete, particularly for the working population.

OBJECTIVES: We aimed to provide information on the prevalence of post-COVID-19 conditions in a subset of the German working-age population (18-61 years old) and to analyze risk factors.

METHODS: We conducted an online survey with a health questionnaire among registered potential stem cell donors with or without a self-reported history of polymerase chain reaction (PCR)-confirmed SARS-CoV-2 infection. Logistic regression models were used to examine the risks of severity of acute infection, sex, age, body mass index, diabetes mellitus, and arterial hypertension medication on post-COVID-19 symptoms.

RESULTS: A total of 199,377 donors reported evaluable survey questionnaires-12,609 cases had a history of SARS-CoV-2 infection and 186,768 controls had none. Overall, cases reported physical, cognitive, and psychological complaints more frequently compared to controls. Increased rates of complaints persisted throughout 15 months postinfection, for example, 28.4%/19.3% of cases/controls reported fatigue (p <0.0001) and 9.5%/3.6% of cases/controls reported loss of concentration (p <0.0001). No significant differences were observed in the frequency of reported symptoms between 3 and 15 months postinfection. Multivariate analysis revealed a strong influence of the severity of the acute SARS-CoV-2 infection episode and age on the risk for post-COVID-19 conditions.

CONCLUSION: We report the prevalence of post-COVID-19 conditions in mainly unvaccinated individuals with SARS-CoV-2 infections between February 2020 and August 2021. The severity of the acute course and age were major risk factors. Vaccinations may reduce the risk of post-COVID-19 conditions by reducing the risk of severe infections.

Details

Original languageEnglish
Pages (from-to)354-370
Number of pages17
JournalJournal of internal medicine
Volume293 (2023)
Issue number3
Publication statusPublished - 13 Nov 2022
Peer-reviewedYes

External IDs

PubMedCentral PMC10107314
Scopus 85144215026

Keywords

Keywords

  • Humans, Adolescent, Young Adult, Adult, Middle Aged, COVID-19/epidemiology, SARS-CoV-2, Cross-Sectional Studies, Risk Factors, Stem Cells

Library keywords